Drug Pricing & Affordability
Expert articles and analysis related to drug pricing & affordability.
AI Summary — Last 30 Days
No recent expert commentary on Drug Pricing & Affordability in the last 30d.
Related Articles
The Limits of Disclosure and the Power of the Outside Option: A Case for External Reference Pricing in Healthcare
By DAVID INTROCASO & ADAM CUNNINGHAM For over a decade, federal healthcare policy has operated on a foundational premise: if hospital prices are made visible, market discipline will inevitably follow....
Drug pricing and the IRA: Tracking the government's negotiation power
Drug pricing and the IRA: Tracking the government's negotiation power Endpoints News
Healthcare price transparency legislation gains momentum in Congress
Price transparency bills continue to be a focus in Congress as an area to pursue in possible year-end healthcare legislation. Two House committees and a Senate committee approved bills within the past...
A Prescription for Drug Costs: Inject Transparency and Improve Accessibility
A Prescription for Drug Costs: Inject Transparency and Improve Accessibility MedCity News
The $48B Payor Nobody Contracts With
Executive Summary While You Were Fighting the 800 Pound Managed Care Gorilla, a New Payor Walked In Every hospital CFO can recite their payor mix from memory: Medicare, Medicaid, commercial, self-pay....
Delaware Implements Measures to Lower Healthcare Costs and Protect Hospitals
Delaware Implements Measures to Lower Healthcare Costs and Protect Hospitals HCI Innovation Group
Comparing the House and Senate Price Transparency in Healthcare Bill
Comparing the House and Senate Price Transparency in Healthcare Bill American Enterprise Institute - AEI
Rise of uninsured patients hits CHS’ finances in Q2
CHS’ financial results fell below internal expectations as the hospital operator served more uninsured patients and surgery volumes declined, executives said.
Infographic: Inside the ACA Disenrollment and Patient Affordability Crisis
Infographic: Inside the ACA Disenrollment and Patient Affordability Crisis HealthLeaders Media
HHS appeals invalidation of 2025 ACA rule
The Trump administration is fighting to restore controversial provisions that a judge threw out last month, including shorter sign-up windows and heightened eligibility verification.